JANX insider plans sale of 118,122 shares

JANX insider Andy Meyer filed a notice of proposed sale under Rule 144 to sell 118,122 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,738,389.66 and 60,147,807 shares outstanding.

Rhea-AI Filing Summary

JANX insider Andy Meyer filed a notice of proposed sale under Rule 144 to sell 118,122 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,738,389.66 and 60,147,807 shares outstanding.

The shares were acquired on 01/23/2026 by exercising options under a registered plan and paid for in cash on the same date. In the past three months, Meyer has sold additional JANX common shares, including 16,665 shares on 10/28/2025 for gross proceeds of $500,314.00, under separate transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JANX shares does Andy Meyer plan to sell under this Form 144?

Andy Meyer plans to sell 118,122 shares of JANX common stock, with an aggregate market value of $1,738,389.66, through Morgan Stanley Smith Barney LLC.

How did Andy Meyer acquire the JANX shares being sold?

The 118,122 JANX common shares to be sold were acquired on 01/23/2026 through an exercise of options under a registered plan, and were paid for in cash on the same date.

What is the total number of JANX shares outstanding mentioned in the filing?

The filing states that the number of JANX common shares outstanding is 60,147,807.

On which exchange are the JANX shares listed for this planned sale?

The JANX common shares covered by this notice are listed for trading on the NASDAQ stock market.

Which broker is handling Andy Meyer’s planned JANX share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What JANX share sales has Andy Meyer completed in the past three months?

In the past three months, Andy Meyer has sold JANX common shares including 16,665 shares on 10/28/2025 for $500,314.00, 3,333 shares on 11/14/2025 for $99,850.00, and 3,333 shares on 12/01/2025 for $109,789.00.

What representation does the seller make about JANX’s information in this notice?

By signing the notice, the seller represents that they do not know any material adverse information about JANX’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 04:08 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001864159
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JANUX THERAPEUTICS, INC.
SEC File Number	001-40475
Address of Issuer	10955 Vista Sorrento Parkway, Suite 200 San Diego CALIFORNIA 92130
Phone	(858) 751-4493
Name of Person for Whose Account the Securities are To Be Sold	ANDY MEYER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	118122	1738389.66	60147807	01/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/23/2026	Exercise of options under a registered plan	Issuer			118122	01/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andy Meyer 10955 Vista Sorrento Parkway, Suite 200 San Diego CA 92130	Common	12/01/2025	3333	109789.00
Andy Meyer 10955 Vista Sorrento Parkway, Suite 200 San Diego CA 92130	Common	11/14/2025	3333	99850.00
Andy Meyer 10955 Vista Sorrento Parkway, Suite 200 San Diego CA 92130	Common	10/28/2025	16665	500314.00

144: Remarks and Signature

Remarks
Date of Notice	01/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Meyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)